After 28 years of proudly leading the University of Michigan Comprehensive Cancer Center, I will be stepping down as the Center’s director.
I have chosen this time to allow for a new center director to prepare for the next NCI core grant renewal which will take place in 2016. A national search will be conducted to identify a new director and the search is expected to take about a year. However, I will remain as director until my successor is named, after which time I will continue both in my clinical practice and with my breast cancer research. My research program in cancer stem cells is now at a particularly exciting phase with the movement of this work into the clinic.
As you likely know, in 2012, the University of Michigan Comprehensive Cancer Center received more National Cancer Institute (NCI) funding than any other university-based cancer center, even as NCI funding for cancer research has declined steadily over the past several years. At the same time, the center’s clinical cancer programs have grown dramatically over the last decade and we have achieved patient satisfaction scores that rank among the best in the University of Michigan Health System. During these past 26 years, we have witnessed remarkable advances in science and technology that hold the promise of revolutionizing cancer treatment.
While we celebrate our accomplishments together, I anticipate that the upcoming transition will provide an exciting opportunity for the Cancer Center to progress even further. I am confident that the excellent leadership and support of the Cancer Center will continue to enhance our mission locally and around the world.
The University of Michigan Comprehensive Cancer Center is a remarkable place with its outstanding researchers and clinicians and those who support them. Thank you for your loyalty, generosity and long-standing support of our mission. We are positioned to remain at the forefront of a cancer revolution because of you, and I will be forever grateful for your devotion to the patients and families we serve.
Max S. Wicha, M.D.
Director, University of Michigan Comprehensive Cancer Center